Drug recall · August 18, 2021
Sulfamethoxazole and Trimethoprim Tablets recall
Why: Presence of Foreign Substance- Potential of metal contamination.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sulfamethoxazole and Trimethoprim Tablets, USP, 800mg/160mg Double Strength, 500 Tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-HIghtstown Road, EAs Windsor, NJ 08520, Made in India, NDC 65862-420-05
- Lots / codes
Batch SP1D19082AA3 & Batch SP1D19085AA3; Exp 08/2022
- Quantity
- 3800 bottles
- Company
- Aurobindo Pharma USA Inc., East Windsor, NJ
- Distribution
- Nationwide
- Initiated
- July 7, 2021 · Voluntary: Firm initiated
- Classified
- August 10, 2021
- Reported
- August 18, 2021
- Ended
- October 18, 2023
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sulfamethoxazole / trimethoprim
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.